CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

PartnershipPositive

AI Analysis

Summary

CellCarta announced a strategic partnership with Waters to advance companion diagnostics development, combining CellCarta's clinical trial testing capabilities with Waters' flow cytometry platforms and expertise.

Importance:5/10

Sentiment:

0.60

partnershipcompanion diagnosticsflow cytometryCROclinical trial testing

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Biotech on October 5, 2026 1:15 PM

Read Original